phase readout
savePhase 3 primary completion: A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
December 30, 2030updated 1mo ago
community read0 votes
Sponsor: Pfizer. Status: Recruiting. Conditions: Sickle Cell Disease. NCT05431088.
view source ↗Data sources
last refreshed 40m ago
Found something off?
comments(0)
5-min edit window · permanent after that